Press Release

Nasal Drug Delivery Devices Market Size, Share, Supply, Demand, Segments and Forecast 2020-2026

Nasal Drug Delivery Devices Market Size, Share, Industry Analysis and Segmentation By Type, By Application, By Distribution Channel and Geography Forecast till 2026

Nasal Drug Delivery Devices MarketThe global nasal drug delivery devices market size is prognosticated to reach USD 81.85 billion by 2026 attributable to the increasing number of the patient population and the rising prevalence of pulmonary disorders worldwide. This information is provided in a recently published report by Fortune Business Insights™ titled, “Nasal Drug Delivery Devices Market Size, Share and Global Trend By Type (Dry Powder Inhalers (DPIs), Metered Dose Inhalers (MDIs), and Nebulizers), By Application (Asthma, Chronic Obstructive Pulmonary Disease (COPD), and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies) and Geography Forecast till 2026.” As per the report’s description, the market size was USD 46.34 billion in 2018 and is likely to exhibit a CAGR of 7.5% between 2019 to 2026.

List of Known Nasal Drug Delivery Technology Market Manufacturers include:

  • Consort Medical plc. (United Kingdom)
  • Teva Pharmaceutical Industries Ltd.
  • H&T Presspart Manufacturing Ltd.
  • 3M
  • Nemera
  • AptarGroup, Inc. (United States)
  • Vectura Group plc (United Kingdom)
  • Others

What are the Key Objectives of this Report?

The report provides a comprehensive overview of the market for nasal drug delivery systems and its various growth parameters. These include factors driving, challenging, and providing opportunities to the market. Besides this, the report discusses the competitive landscape and lists the names of players operating in the market and the major strategies adopted by them. Adoption of different strategies will help key players to strive for the leading position in the market. It also discusses the key segments in the market based on factors such as type, application, end user, distribution channel, and others. Additionally, the report provides insights into the market, major industry developments, and current nasal drug delivery devices market trends. It is available for sale on the company website.

Market Drivers:

Rising Awareness About Nasal Spray and its Benefits will Help Market Gain Impetus

The increasing prevalence of respiratory disorders among people is a major factor boosting the nasal drug delivery devices market growth. Additionally, the increasing prevalence of asthma and chronic obstructive pulmonary disease (COPD) cases is also aiding to the expansion of the market for pulmonary drug delivery devices. Besides this, analyst at Fortune Business Insights™ says, “The increasing patient population and the rising demand for inhalers are encouraging companies to set up new manufacturing units. This is further expected to drive the overall market in the forecast period.”

On the flipside, lack of awareness about inhalers along with their usage, especially amongst the older population may cause hindrance to the overall market. Nevertheless, the rising awareness about the benefits of DPIs and MDIs is expected to help increase their popularity in the market. This, as a result, will give significant impetus to the market in the long run.

Regional Analysis

Europe to Dominate Owing to Rising Prevalence of Asthma

Geographically, the global nasal drug delivery devices market is categorized into North America, Europe, Latin America, Asia Pacific, and the Middle East and Africa. Among these, Europe is holding the largest share with a nasal drug delivery technology market revenue of USD 21.1 billion in 2018. This dominance is attributable to the increasing prevalence of asthma, coupled with the rise in awareness about nasal sprays and their benefits. Besides this, there is the rising popularity of inhalers in developing nations of this region, thereby boosting the regional market.

Apart from this, Asia Pacific market share is likely to attract significant nasal drug delivery devices market share owing to the rise in awareness campaigns about the use of inhalers and its benefits. Moreover, biopharma companies are utilizing novel technologies for introducing MDI and DPI into the regional market for higher revenue generation during the forecast period.

More Trending Topics from Fortune Business Insights:

Urine Meter Trays Market Analysis, Size, Share, Trends, Market Demand, Growth, Opportunities and Forecast 2026

Respiratory Drugs Market Global Industry Size, In-Depth Insights, Explosive Growth Opportunity, Forecast to 2026

Ocular Implants Market Global Industry Size, Trends, Global Growth, Insights and Forecast Research Report 2025

Rapid Advancements in Platelet Rich Plasma Market to Fuel Revenues Through 2020-2026


Dale Martinez

Dale possesses an engineering degree in Electronics from the Georgia Institute of Technology. She is the sole contributor at the Healthcare IT column. Before opting to write, Dale worked at major firms such as Microsoft, Amazon, GE, Raytheon, and so on. She possesses vast knowledge about a variety of fields like IT, IoT, Telecommunications, Health Dialysis, photovoltaic, and many others. Dale is also a ballet dancer.

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Check Also